Abstract:Editor'China is facing a blood shortage.1Jin YH Cui J Solution for the problem of blood short supply from the perspective of surgical appropriate transfusion.Chin J Blood Transfusion. 2011; 24 ([Chinese]): 451-453Google Scholar Approximately 60% of blood products are being transfused during clinical surgery.2Gong BL Zhang W Meng QL et al.A survey of blood supply in 357 provincial and municipal blood banks.Chin J Blood Transfusion. 2012; 25 ([Chinese]): 1248-1250Google Scholar We aimed to assess the appropriateness of perioperative red blood cells (RBCs) transfusion in public tertiary general hospitals in China. This study was designed as a retrospective (January 2006–December 2009) multicentre survey involving three typical sample hospitals [The Peking Union Medical College Hospital (PUMC Hospital), the Second Affiliated Hospital of Zhejiang University School of Medicine (SAZU Hospital), and the Northern Jiangsu People's Hospital (NJP Hospital)]. Using a year-stratified random sampling with a sampling proportion of 20% for every stratum, 6384 patients who had a history of RBCs transfusion were selected from three hospitals. Of them, 1274 patients, who had complete records of objective indication, were included in the appropriateness evaluation. A structural survey form was used to extract data from the medical records, which included the patients' general information, surgical information, objective transfusion indication, and blood infusion information. The appropriateness evaluation consisted of two steps. First, a reasonableness evaluation was done by a composite criterion that was mainly based on Chinese blood transfusion guidance.3National Health and Family Planning Commission of China Technological Specification for Clinical Use of Blood.Available from http://www.moh.gov.cn/mohyzs/s3589/200804/18676.shtmlGoogle Scholar, 4Emmanuel JC The Clinical Use of Blood. World Health Organization, Malta2001: 255-278Google Scholar, 5Carson JL Grossman BJ Kleinman S Red blood cell transfusion: a clinical practice guideline from the AABB.Ann Intern Med. 2012; 157: 49-58Crossref PubMed Scopus (816) Google Scholar, 6British Committee for Standards in Haematology (BCSH) Guideline on the administration of blood components.Available from http://www.bcshguidelines.com/documents/BCSH_Blood_Admin_-_addendum_August_2012.pdfGoogle Scholar Then, over-transfusion7NHS Blood and Transplant Comparative audit of red cell use in the hospitals in the South West and West Midlands regions.Available from http://hospital.blood.co.uk/library/pdf/Audit_of_Red_cell_Use_in%202_regions_St_Elsewhere's_Hospital.pdfGoogle Scholar was further assessed among patients who were identified as reasonable transfusion based on the first step. During the study periods, the whole blood transfusion was almost replaced by blood component transfusion after the year 2007. The proportion of blood component transfusion increased from 92.3% in 2006 to 99.6% in 2009. Overall, the unreasonable RBCs transfusion rate significantly decreased from 41.5% [95% confidence interval (CI): 35.2–47.9] to 30.2% (25.9–34.7) during the study periods. The downtrends were consistent in all subgroups (38.7–28.8%, 45.2–23.5%, and 41.9–38.9% at the PUMC, the SAZU, and the NJP Hospital, respectively, all P<0.05). Table 1 shows the distribution characteristics of patients who have undergone unreasonable RBCs transfusions. The unreasonable rate in thoracic surgery patients was highest [56.8% (46.3–67.0)], followed by heart/blood vessel surgery patients [47.7% (39.7–55.9)]. Patients without anaemia on admission had more than twice the unreasonable rate as did anaemia patients, especially at the SAZU (64.7% vs 17.9%, P<0.0001) and the NJP Hospital (68.7% vs 24.2%, P<0.0001). In fact, when surgical acute blood loss was replaced by crystalloid or colloid fluids to maintain normovolaemia, in most stable hospitalized patients with adequate preoperative haemoglobin, the loss could often be well tolerated due to normal compensatory responses that are invoked before a blood transfusion becomes necessary.4Emmanuel JC The Clinical Use of Blood. World Health Organization, Malta2001: 255-278Google Scholar, 5Carson JL Grossman BJ Kleinman S Red blood cell transfusion: a clinical practice guideline from the AABB.Ann Intern Med. 2012; 157: 49-58Crossref PubMed Scopus (816) Google ScholarTable 1Distribution characteristics of patients who were identified as unreasonable RBCs transfusions. *95% CIPUMC HospitalSAZU HospitalNJP HospitalTotalUnreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Gender Male108/25542.4 (36.2–48.7)59/14540.7 (32.6–49.2)76/16047.5 (39.6–55.5)243/56043.4 (39.2–47.6) Female100/34628.9 (24.2–34.0)39/13129.8 (22.1–38.4)65/14744.2 (36.0–52.6)204/62432.7 (29.0–36.5)Anaemia on admission Non-anaemia146/30248.3 (42.6–54.1)66/10264.7 (54.6–73.9)103/15068.7 (60.6–76.0)315/55456.9 (52.6–61.0) Anaemia63/28921.8 (17.2–27.0)31/17317.9 (12.5–24.5)37/15324.2 (17.6–31.8)131/61521.3 (18.1–24.8)Operative sites Head/neck17/3351.5 (33.5–69.2)7/3023.3 (9.9–43.4)14/2458.3 (36.6–77.9)38/8743.7 (33.1–54.7) Thoracic14/3540.0 (23.8–57.9)5/1145.5 (16.8–76.6)35/4971.4 (56.7–83.4)54/9556.8 (46.3–67.0) Abdomen91/28132.4 (27.0–38.2)32/9035.6 (25.7–46.4)49/13835.5 (27.6–44.1)172/50933.8 (29.7–38.1) Limbs/spinal column52/15134.4 (26.9–42.6)41/12433.1 (24.9–42.1)17/6426.6 (16.3–39.1)110/33932.4 (27.5–37.7) Heart/blood vessel35/10234.3 (25.2–44.4)13/2161.9 (38.4–81.9)26/3281.3 (63.6–92.8)74/15547.7 (39.7–55.9) Open table in a new tab Overall, the over-transfusion rate was 10.1%. Nearly, half of the over-transfusion episodes occurred in abdominal operations (consistently in three hospitals). Abdominal surgery accounted for the highest proportion of all surgeries (37.6%) and consumed the largest number of RBCs transfusions (38.4%). Improved transfusion practices during abdomen surgery might conserve scarce blood resources largely because of its substantial operation quantity. After controlling for the hospital, the over-transfusion rate in patients without anaemia on admission was significantly higher than that in anaemic patients (16.9% vs 6.8%, P<0.0001). This study suggests that perioperative blood transfusion is gradually being standardized in China. However, rational blood usage still requires improvements. The low proportion of patients who have complete indication records indicated that an objective indication-guided blood transfusion needs to be further strengthened. Patients who had undergone thoracic, abdominal surgery, or without anaemia on admission were considered as potential populations for blood conservation. Our results are unlikely to be conclusive because of the typical sampling design. Nevertheless, these data have sounded alarm bells for perioperative blood conservation in China. None declared. National Health and Family Planning Commission of the People's Republic of China.

Blood donation: NHS issues urgent appeal amid "unprecedentedly low" stocks

Blood donation: NHS stocks are still in short supply after June cyberattack

Mitigating the impact of blood shortages in England

How do I manage a blood product shortage?

Impact of the COVID‐19 outbreak on blood supply in two large university hospitals

Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak

The global need and availability of blood products: a modelling study

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey

Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey

Use of half red blood cell units in oncology patients during severe shortages to extend hospital supply

Slowing decline in blood collection and transfusion in the United States – 2017

Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providers

Multicentre Evaluation of Perioperative Red Blood Cells Transfusions in China

Transfusion in limited infrastructure locations – where to go decades after safe blood initiative by World Health Organization?

Through the Eyes of the Recipient: Navigating Transfusion Services Amidst COVID-19 in Multi-Transfused Thalassaemic Patients

Factors Associated with Red Blood Cell Transfusion among Hospitalized Patients: a Cross-Sectional Study.

Supplemental findings of the 2021 National Blood Collection and Utilization Survey

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

A further update on mortality and morbidity in patients with very low hemoglobin levels who decline blood transfusion

The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial

Type-specific whole blood still has a role in the era of low titer O universal donor transfusion for severe trauma hemorrhage